Evidence map›Paper›PMID 26697481›Full record

ArticleAnnals of translational medicine2015

Metastatic colorectal cancer in a cirrhotic liver with synchronous hepatocellular carcinoma.

Michael Karass, Emily Grossniklaus, Talal Seoud, Ralph Kamel, Oluwadamilola Teniola, Gabriela Oprea, Daniel A Goldstein, Sanjay Jain

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael Karass1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.
Emily Grossniklaus1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.
Talal Seoud1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.
Ralph Kamel1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.
Oluwadamilola Teniola1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.
Gabriela Oprea1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.
Daniel A Goldstein1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.
Sanjay Jain1 New York Medical College, Valhalla, NY 10905, USA ; 2 Emory University, Atlanta, GA 30322, USA ; 3 American University of Beirut, Beirut, Lebanon ; 4 Saint Joseph University, Beirut, Lebanon ; 5 Morehouse School of Medicine, Atlanta, GA 30310, USA.

Funding

Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
NCATS NIH HHS UL1 TR001073
6 · The paper itself

Abstract

We are reporting a case of a patient with a previous history of colorectal cancer (CRC) and cirrhosis, who developed concurrent liver lesions consistent with hepatocellular carcinoma (HCC); a case which is unique due to the low incidence of multiple cancers, particularly HCC in the setting of previous advanced colorectal carcinoma along, in a cirrhotic liver. We will review the known literature on multiple cancer rates found in patients with known colorectal carcinoma. We will then outline this particular patient's presentation, followed by a discussion as to why the particular concurrent development of HCC in the setting of previous CRC is of note.

Indexed as

cancercirrhosisColorectal cancer (CRC)hepatocellular carcinoma (HCC)metastasesmetastaticoncology

Identifiers

PMID26697481
PMCPMC4669328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.